Back to Search Start Over

Narrative review of the role of artificial intelligence to improve aortic valve disease management

Authors :
Universidad de Sevilla. Departamento de Farmacia y Tecnología Farmacéutica
Thoenes, Martin
Agarwal, Anurag
Grundmann, David
Ferrero Rodríguez, Carmen
McDonald, Andrew
Bramlage, Peter
Steeds, Richard P.
Universidad de Sevilla. Departamento de Farmacia y Tecnología Farmacéutica
Thoenes, Martin
Agarwal, Anurag
Grundmann, David
Ferrero Rodríguez, Carmen
McDonald, Andrew
Bramlage, Peter
Steeds, Richard P.
Publication Year :
2021

Abstract

Valvular heart disease (VHD) is a chronic progressive condition with an increasing prevalence in the Western world due to aging populations. VHD is often diagnosed at a late stage when patients are symptomatic and the outcomes of therapy, including valve replacement, may be sub-optimal due the development of secondary complications, including left ventricular (LV) dysfunction. The clinical application of artificial intelligence (AI), including machine learning (ML), has promise in supporting not only early and more timely diagnosis, but also hastening patient referral and ensuring optimal treatment of VHD. As physician auscultation lacks accuracy in diagnosis of significant VHD, computer-aided auscultation (CAA) with the help of a commercially available digital stethoscopes improves the detection and classification of heart murmurs. Although used little in current clinical practice, CAA can screen large populations at low cost with high accuracy for VHD and faciliate appropriate patient referral. Echocardiography remains the next step in assessment and planning management and AI is delivering major changes in speeding training, improving image quality by pattern recognition and image sorting, as well as automated measurement of multiple variables, thereby improving accuracy. Furthermore, AI then has the potential to hasten patient disposal, by automated alerts for red-flag findings, as well as decision support in dealing with results. In management, there is great potential in ML-enabled tools to support comprehensive disease monitoring and individualized treatment decisions. Using data from multiple sources, including demographic and clinical risk data to image variables and electronic reports from electronic medical records, specific patient phenotypes may be identified that are associated with greater risk or modeled to the estimate trajectory of VHD progression. Finally, AI algorithms are of proven value in planning intervention, facilitating transcatheter valve

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1367116444
Document Type :
Electronic Resource